Expression of NM23 in human melanoma progression and metastasis

British Journal of Cancer

Volumn 74, Issue 1, 1996, Pages 109-114

  Easty, D J ^a   Maung, K ^a   Lascu, I ^b,c   Veron M ^b   Fallowfield, M E ^d   Hart, I R ^e   Bennett, D C ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d Department of Dermatology ^*  (United Kingdom)

^e ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Human melanoma; Metastasis; NM23

Indexed keywords

ANTIBODY; MESSENGER RNA; NUCLEOSIDE DIPHOSPHATE KINASE; PROTEIN;

ARTICLE; CANCER GENETICS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MELANOCYTE; MELANOMA; METASTASIS; NEVUS; NORTHERN BLOTTING; PRIORITY JOURNAL; SKIN; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 0030036186     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.323     Document Type: Article

References (37)

1. BERTHEAU P, DE LA ROSA A, STEEG PS AND MERINO MJ. (1994). NM23 protein in neoplastic and nonneoplastic thyroid tissues. Am. J. Pathol., 145, 26-32.
2. BEVILACQUA G, SOBEL ME, LIOTTA LA AND STEEG PS. (1989). Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res., 49, 5185-5190.
3. CHANG CL, ZHU X-X, THORAVAL DH, UNGAR D, RAWWAS J, HORA N, STRAHLER JR, HANASH SM AND RADANY E. (1994). nm23-H1 mutation in neuroblastoma. Nature, 370, 335-336.
4. CLARK WH, ELDER DE, GUERRY D, BRAITMAN LE, TROCK BJ, SCHULTZ D, SYNNESTVEDT M AND HALPERN AC. (1989). Model predicting survival in stage I melanoma based on tumor progression. J. Natl Cancer Inst., 81, 1893-1904.
5. DORUDI S AND HART IR. (1993). Mechanisms underlying invasion and metastasis. Curr. Opin. Oncol., 5, 130-135.
6. EASTY DJ, GANZ SE, FARR CJ, LAI C, HERLYN M AND BENNETT DC. (1993). Novel and known protein tyrosine kinases and their abnormal expression in human melanoma. J. Invest. Dermatol., 101, 679-684.
7. EASTY DJ, GUTHRIE BA, MAUNG K, FARR CJ, LINDBERG RA, TOSO RJ, HERLYN M AND BENNETT DC. (1995a). Protein B61 as a new growth factor: expression of B61 and upregulation of its receptor epithelial cell kinase during melanoma progression. Cancer Res., 55, 2528-2532.
8. EASTY DJ, HERLYN M AND BENNETT DC. (1995b). Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis. Int. J. Cancer, 60, 129-136.
9. FEINBERG AP, AND VOGELSTEIN B. (1984). A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Addendum. Anal. Biochem., 137, 266-267.
10. FIDLER IJ AND RADINSKY R. (1990). Genetic control of cancer metastasis. J. Nutl Cancer Inst., 82, 166-168.
11. FLØRENES VA, AAMDAL S, MYKLEBOST O, MAELANDSMO GM, BRULAND ØS AND FODSTAD Ø. (1992). Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res., 52, 6088-6091.
12. GILLES AM, PRESECAN E, VONICA A AND LASCU I. (1991). Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J. Biol. Chem., 266, 8784-8789.
13. HAILAT N, KEIM DR, MELHEM RF, ZHU X-X, ECKERSKORN C, BRODEUR GM, REYNOLDS CP, SEEGER RC, LOTTSPEICH F, STRAHLER JR AND HANASH SM.(1991). High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J. Clin. Invest., 88, 341-345.
14. HART IR AND EASTY DJ. (1991). Identification of genes controlling metastatic behaviour. Br. J. Cancer, 63, 9-12.
15. HENNESSY C, HENRY JA, MAY FEB, WESTLY BR, ANGUS B AND LENNARD TWJ. (1991). Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J. Natl Cancer Inst., 83, 281-285.
16. HERLYN D, ILIOPOULOS D, JENSEN PJ, PARMITER A, BAIRD J, HOTTA H, ADACHI K, ROSS AH, JAMBROSIC J, KOPROWSKI H AND HERLYN M. (1990). In vitro properties of human melanoma cells metastatic in nude mice. Cancer Res., 50, 2296-2302.
17. HIGASHIYAMA M, DOI O, YOKOUCHI H, KODAMA K, NAKAMORI S, TATEISHI R AND KIMURA N. (1992). Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma: lack of prognostic value. Br. J. Cancer, 66, 533-536.
18. HIRAYAMA R, SAWAI S, TAKAGI Y, MISHIMA Y, KIMURA N, SHIMADA N, ESAKI Y, KURASHIMA C, UTSUYAMA M AND HIROKAWA K. (1991). Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer. J. Natl Cancer Inst., 83, 1249-1250.
19. LACOMBE M-L, SASTRE-GARAU X, LASCU I, VONICA A, WALLET V, THIERY JP AND VERON M. (1991). Overexpression of nucleoside diphosphate kinase (Nm23) in solid tumours. Eur. J. Cancer, 27, 1302-1307.
20. LEONE A, FLATOW U, KING CR, SANDEEN MA, MARGULIES IMK, LIOTTA LA AND STEEG PS. (1991). Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell, 65, 25-35.
21. LEONE A, SEEGER RC, HONG CM, HU YY, ARBOLEDA MJ, BRODEUR GM, SLAMON DJ AND STEEG PS. (1993). Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastoma. Oncogene, 8, 835-865.
22. LEVINE AJ. (1993). The tumor suppressor genes. Annu. Rev. Biochem., 62, 623-651.
23. LIOTTA LA, STEEG PS AND STETLER-STEVENSON WG. (1991). Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-336.
24. MACDONALD NJ AND STEEG PS. (1993). Molecular basis of tumor metastasis. Cancer Surv., 16, 175-199.
25. MACDONALD NJ, DE LA ROSA A, BENEDICT MA, FREIJE JMP, KRUTSCH H AND STEEG PS. (1993). A serine phosphorylation of nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J. Biol. Chem., 268, 25780-25789.
26. MORSE HG AND MOORE GE. (1993). Cytogenetic homogeneity in eight independent sites in a case of malignant melanoma. Cancer Genet. Cytogenet., 69, 108-112.
27. OKABE-KADO J, KASUKABE T, HONMA Y, HAYASHI M, HENZEL WJ AND HOZUMI M. (1992). Identity of a differentiation inhibiting factor for mouse myeloid leukaemia cells with nm23/ nucleoside diphosphate kinase. Biochem. Biophys. Res. Commun., 182, 987-994.
28. ORMEROD EJ, EVERETT CA AND HART IR. (1986). Enhanced experimental metastatic capacity of a human tumor line following treatment with 5-azacytidine. Cancer Res., 46, 884-890.
29. 2+ and the calmodulin inhibitor W-7 alter the expression of metastasis-associated genes MTS1 and NM23 in metastatic variants of the B16 murine melanoma. Melanoma Res., 2, 337-343.
30. POSTEL EH, BERBERICH SJ, FLINT SJ AND FERRONE CA. (1993). Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science, 261, 478-480.
31. RADINSKY R, WEISBERG HZ, STAROSELSKY AN AND FIDLER IJ. (1992). Expression level of the nm23 gene in clonal populations of metastatic murine and human neoplasms. Cancer Res., 52, 5808-5814.
32. SASTRE-GARAU X, LACOMBE ML, JOUVE M, VÉRON M AND MAGDELENAT H. (1992). Nucleoside diphosphate kinase/nm23 expression in breast cancer: lack of correlation with lymph-node metastasis. Int. J. Cancer, 50, 533-538.
33. SAWAN A, LASCU I, VÉRON M, ANDERSON JJ, WRIGHT C, HORNE CHW AND ANGUS B. (1994). NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study. J. Pathol., 172, 27-34.
34. STEEG PS, BEVILACQUA G, KOPPER L, THORGEIRSSON UP, TALMADGE JE, LIOTTA LA AND SOBEL ME. (1988). Evidence for a novel gene associated with low tumor metastatic potential. J. Natl Cancer Inst., 80, 200-204.
35. TOKUNAGA Y, URANO T, FURUKAWA K, KONDO H, KANEMATSU T AND SHIKU H.(1993). Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph node metastases of human breast cancer. Int. J. Cancer, 55, 66-71.
36. WARBURTON MJ, MITCHELL D, ORMEROD EJ AND RUDLAND PS. (1982). Distribution of myoepithelial cells and basement membrane proteins in the resting, pregnant, lactating, and involuting rat mammary gland. J. Histochem. Cytochem., 30, 667-676.
37. XERRI L, GROB JJ, BATTYANI Z, GOUVERNET J, HASSOUN J AND BONERANDI JJ. (1994). NM23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival. Br. J. Cancer, 70, 1224-1228.